Article

Efficacy of clinical guidelines in identifying all Japanese patients with hereditary breast and ovarian cancer

2022-02-09

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold>Clinical screening using the National Comprehensive Cancer Network (NCCN) testing criteria may fail to identify all patients with hereditary breast and ovarian cancers.<bold> </bold>Thus,<bold> </bold>this study aimed to evaluate the strategy of expanding target patients for genetic testing among Japanese patients. <bold>Patients and Methods</bold>We reviewed the med...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 37ae63c9-ae60-5996-a0b9-5351f07c3572
DOI: 10.21203/rs.3.rs-1302526/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy of clinical guidelines in identifying all Japanese patients with hereditary breast and ovarian cancerDOI 10.21203/rs.3.rs-1302526/v1Read

Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.Semantic proximity Read

BRCA testing and Japanese original testing criteria for hereditary breast and ovarian cancer covered by public health insuranceSemantic proximity Read

Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.Semantic proximity Read

Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese Organization of Hereditary Breast and Ovarian Cancer registry dataSemantic proximity Read

The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.Semantic proximity Read

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.Semantic proximity Read

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?Semantic proximity Read

NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian CancerSemantic proximity Read

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Semantic proximity Read

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.Semantic proximity Read

Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among high-risk Chinese individualsSemantic proximity Read

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.Semantic proximity Read